Papillomavirus virus like particle-based therapeutic vaccine against human papillomavirus infection related diseases: Immunological problems and future directions
Authors:
- Jiezhong ChenJCJiezhong Chen
- Guoying NiGNGuoying Ni
- Xiao Song LiuXLXiao Song Liu
- 1 January 2011
- journal article
- review article
- Published by Elsevier in Cellular Immunology
- Vol. 269 (1) , 5-9
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Vaccine Adjuvants: Putting Innate Immunity to WorkImmunity, 2010
- Development of therapeutic HPV vaccinesThe Lancet Oncology, 2009
- An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial resultsVaccine, 2008
- Cytomegalovirus exploits IL-10–mediated immune regulation in the salivary glandsJournal of Experimental Medicine, 2007
- Prophylactic HPV vaccines: prospects for eliminating ano-genital cancerBritish Journal of Cancer, 2007
- High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-upBritish Journal of Cancer, 2006
- Interleukin-10 determines viral clearance or persistence in vivoNature Medicine, 2006
- Resolution of a chronic viral infection after interleukin-10 receptor blockadeJournal of Experimental Medicine, 2006
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006
- Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysisBritish Journal of Cancer, 2003